Tsubota Laboratory Incorporated engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and brain diseases in Japan, China, France, and internationally. The company was incorporated in 2012 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does Tsubota Laboratory Incorporated (4890) operate in?
Tsubota Laboratory Incorporated belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Tsubota Laboratory Incorporated (4890) current stock price?
As of the latest data, Tsubota Laboratory Incorporated stock price is ¥251, with a previous close of ¥258. Tsubota Laboratory Incorporated lost -¥7 in the last trading session, representing a -2.71% loss.
What is Tsubota Laboratory Incorporated (4890) current market capitalization?
Tsubota Laboratory Incorporated market cap is approximately 6.47 billion.
What is Tsubota Laboratory Incorporated (4890) Earnings Per Share (EPS)?
The trailing EPS is -¥30.
What is Tsubota Laboratory Incorporated (4890) EBITDA?
Tsubota Laboratory Incorporated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -167.26 million.
Does Tsubota Laboratory Incorporated (4890) pay dividends?
No. Tsubota Laboratory Incorporated does not pay a dividend.
What is Tsubota Laboratory Incorporated (4890) beta (volatility) score?
Tsubota Laboratory Incorporated has a beta of 1.163, meaning its volatility is roughly in line with the market.